| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
1.00 µM |
SK-MEL-5 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
2.00 µM |
SK-MEL-5 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
3.00 µM |
SK-MEL-5 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
4.00 µM |
SK-MEL-5 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
5.00 µM |
SK-MEL-5 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Cell viability |
ELISA |
10.00 µM |
SK-MEL-5 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Inhibition of Jak/STAT signalling |
Western Blot |
10.00 µM |
SK-MEL-5 |
Homo sapiens |
|
p-STAT3 |
|
| BBMD3 (berbamine derivative) |
Inhibition of Jak/STAT signalling |
Western Blot |
10.00 µM |
SK-MEL-5 |
Homo sapiens |
|
STAT3 |
|
| BBMD3 (berbamine derivative) |
Inhibition of Jak/STAT signalling |
Western Blot |
10.00 µM |
SK-MEL-5 |
Homo sapiens |
|
|
|
| BBMD3 (berbamine derivative) |
Inhibition of Jak/STAT signalling |
Western Blot |
10.00 µM |
SK-MEL-5 |
Homo sapiens |
|
|
|
